Orikine Bio S.L.
Latest round
- Seed
Last raised
- Jul 2023
Total raised
- $6.1M
Investors
- 2
About Orikine Bio S.L.
L. is a spin-off from the Centre for Genomic Regulation (CRG) and operates as a biotech company focused on the treatment of immune-mediated diseases through the development of engineered cytokines.L.L. platform produces cytokines that are vital immune system proteins that act as soluble messengers, controlling various immune responses. The cytokine-based therapies target autoimmune and inflammatory diseases. Additionally, the company's platform's versatility allows the development of new drugs for a wide range of immune-based diseases.
Who invested in Orikine Bio S.L.
2 investors across 1 round
See all investors in Orikine Bio S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 18, 2023
Amount
$6.1M
Investors
Questions about Orikine Bio S.L.
Who invested in Orikine Bio S.L.?
Orikine Bio S.L. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orikine Bio S.L. raised?
Orikine Bio S.L. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Orikine Bio S.L. last raise money?
Orikine Bio S.L.'s most recent round on record is a Seed, in Jul 2023.
What does Orikine Bio S.L. do?
Orikine Bio S.L. is a biotechnology company.
Where is Orikine Bio S.L. headquartered?
Orikine Bio S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Orikine Bio S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Orikine Bio S.L.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Orikine Bio S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.